Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation by Pacora, Percy et al.
J. Perinat. Med. 37 (2009) 503–511 • Copyright  by Walter de Gruyter • Berlin • New York. DOI 10.1515/JPM.2009.093
Article in press - uncorrected proof
Amniotic fluid angiopoietin-2 in term and preterm parturition,
and intra-amniotic infection/inflammation
Percy Pacora1, Roberto Romero1–3,*, Tinnakorn
Chaiworapongsa1,2, Juan Pedro Kusanovic1,2,
Offer Erez1,2, Edi Vaisbuch1,2, Shali Mazaki-
Tovi1,2, Francesca Gotsch1, Chong Jai Kim1,4,
Nandor Gabor Than1, Lami Yeo1,2, Pooja
Mittal1,2 and Sonia S. Hassan1,2
1 Perinatology Research Branch, NICHD/NIH/DHHS,
Bethesda, Maryland and Detroit, Michigan, USA
2 Department of Obstetrics and Gynecology, Wayne
State University School of Medicine, Detroit, MI, USA
3 Center for Molecular Medicine and Genetics, Wayne
State University School of Medicine, Detroit, MI, USA
4 Department of Pathology, Wayne State University
School of Medicine, Detroit, MI, USA
Abstract
Objective: Recent observations have revealed an inter-
action between inflammation and angiogenesis, which
may be mediated by angiopoietins and chemokines.
Given the importance of inflammation in parturition, we
sought to determine whether angiopoietin-2 (Ang-2) is
present in amniotic fluid (AF) and if its concentration
changes with gestational age, labor, and in intra-amniotic
infection/inflammation (IAI) in patients with spontaneous
preterm labor and intact membranes.
Study design: This cross-sectional study included 486
patients in the following groups: 1) women in the mid-
trimester of pregnancy (14–18 weeks) who underwent
amniocentesis for genetic indications and delivered a
normal neonate at term (ns52); 2) normal pregnant
women at term with (ns48) and without (ns45) spon-
taneous labor; 3) patients with an episode of spontane-
ous preterm labor (PTL) and intact membranes who were
classified into: a) PTL without IAI who delivered at term
(ns152); b) PTL without IAI who delivered preterm
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(ns82). Ang-2 concentration in AF was determined by
enzyme-linked immunoassay. Non-parametric statistics
were used for analysis.
Results: 1) Ang-2 was detected in all AF samples; 2) the
median AF Ang-2 concentration at term was significantly
lower than that in the mid-trimester (1877.4 pg/mL vs.
3525.2 pg/mL; P-0.001); 3) among patients with PTL,
the median AF Ang-2 concentration was significantly
higher in patients with IAI than in those without IAI
(4031.3 pg/mL vs. 2599.4 pg/mL; P-0.001) and those
with PTL without IAI who delivered at term (4031.3
pg/mL vs. 2707.3 pg/mL; P-0.001); and 4) no significant
differences were observed in the median AF Ang-2 con-
centration between patients with spontaneous labor at
term and those at term not in labor (1722.9 pg/mL
vs. 1877.4 pg/mL; Ps0.6).
Conclusions: 1) Ang-2, a protein involved in the process
of vascular remodeling, is a physiologic constituent of the
amniotic fluid and its concentration decreased with
advancing gestation; 2) the median Ang-2 concentration
in amniotic fluid is higher in patients with IAI than in those
without; and 3) spontaneous parturition at term is not
associated with changes in the AF concentration of
Ang-2. These findings support the view of a link between
angiopoietins and inflammation.
Keywords: Angiogenesis; chorioamnionitis; microbial
invasion of the amniotic cavity; pregnancy; preterm deliv-
ery, preterm labor; preterm parturition syndrome, Tie-2;
vasculogenesis.
Introduction
Angiogenesis is the process by which new vessels are
formed from pre-existing vasculature. This process is
tightly regulated by different families of growth factors.
Along with the well-characterized vascular endothelial
growth factor (VEGF) family, angiopoietins have been
shown to be critical in orchestrating blood vessel for-
mation w8x. Angiopoietin-1 (Ang-1) and angiopoietin-2
(Ang-2) are structurally-related endothelial growth fac-
tors. They bind with similar specificity and affinity to the
tyrosine kinase receptor with immunoglobulin and epi-
dermal growth factor homology domain 2 (Tie-2), which
is expressed on endothelial cells and hemopoietic cells
w12, 33, 60x. Studies in knockout mice have shown that
the Ang-1/Tie-2 system plays an essential role in embry-
onic vascular remodeling w60, 63x. Under physiologic
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conditions, Ang-1, through Tie-2 signaling, mediates ves-
sel maturation and maintains vessel integrity by the
recruitment of periendothelial cells w31x.
Ang-2 is a competitive inhibitor of Ang-1 because both
bind to Tie-2 tyrokinase receptor w12, 33, 60x. Ang-1
induces phosphorylation of Tie-2, whereas Ang-2 binding
does not activate the receptor w33x. Remarkably, Ang-2
acts only as an antagonist of Ang-1 on endothelial cells,
leads to loosening of cell/cell interactions and allows
access to angiogenic inducers such as VEGF w33x. Ang-
2 may act with VEGF to promote angiogenic sprouting
from established vasculature w18, 33x. Thus, Ang-2 is
specifically required for normal postnatal vessel remod-
eling w18x.
Parturition is considered to be an inflammatory pro-
cess w24, 49, 52, 54x. In addition, the expression of
angiogenesis-related genes is significantly increased in
the mouse uterus during spontaneous labor at term, as
well as induced preterm labor by either bacteria or ovar-
iectomy w23x. These findings suggest that changes in
gene expression of angiogenic-related genes are part of
the common pathway of parturition.
Since there is a paucity of information about the role
of Ang-2 in human amniotic fluid, we determined whether
Ang-2 is present in human amniotic fluid and if its con-
centration changes with gestational age, in the presence
of labor (term and preterm), and in intra-amniotic infec-
tion/inflammation (IAI) in patients with spontaneous pre-
term labor and intact membranes.
Materials and methods
Study design and population
A cross-sectional study was designed by searching our clinical
database and bank of biological samples including 486 patients
in the following groups: 1) women in the mid-trimester of preg-
nancy (14–18 weeks) who underwent amniocentesis for genetic
indications and delivered a normal neonate at term (ns52);
2) normal pregnant women at term with (ns48) and without
(ns45) spontaneous labor; and 3) patients with an episode of
spontaneous preterm labor (PTL) and intact membranes who
were classified into: a) PTL without IAI who delivered at term
(ns152); b) PTL without IAI who delivered preterm (-37 weeks’
gestation; ns107); and c) PTL with IAI (ns82).
Definitions
Patients were considered to have a normal pregnancy outcome
if they did not have any medical, obstetrical, or surgical
complications and delivered a term neonate (G37 weeks) of
greater than the 10th percentile for gestational age w1, 22x without
complications. Spontaneous preterm labor was defined by the
presence of regular uterine contractions occurring at a frequency
of at least two every 10 min associated with cervical changes
before 37 completed weeks of gestation that required hospital-
ization. Intra-amniotic infection was defined as a positive amni-
otic fluid culture for microorganisms. Intra-amniotic inflammation
was diagnosed by an amniotic fluid interleukin (IL)-6 concentra-
tion G2.6 pg/mL w68x. Histologic chorioamnionitis was diag-
nosed based on the presence of inflammatory cells in the
chorionic plate and/or chorioamniotic membranes. Acute funi-
sitis was diagnosed by the presence of neutrophils in the wall
of the umbilical vessels and/or Wharton’s jelly, using criteria pre-
viously described w41x.
Sample collection
Amniotic fluid samples were obtained from transabdominal
amniocentesis performed for genetic indications, evaluation of
microbial status of the amniotic cavity, and/or assessment of
fetal lung maturity in patients approaching term. Women at term
in labor consisted of women who were admitted for suspected
preterm labor because of uncertain dates and had an amnio-
centesis for the assessment of fetal lung maturity. The criteria
for determining that these patients were at term was derived
retrospectively, if the following criteria were met: 1) spontaneous
labor; 2) delivery within 24 hours from amniocentesis; 3) analysis
of amniotic fluid consistent with fetal lung maturity; 4) birth-
weight )2500 g; 5) absence of respiratory distress syndrome or
other complications of prematurity; and 6) physical examination
of the newborn by pediatricians which was consistent with a
term neonate. Samples of amniotic fluid were transported to the
laboratory in a sterile capped syringe and cultured for aerobic/
anaerobic bacteria and genital mycoplasmas. White blood cell
(WBC) count, glucose concentration and Gram-stain were also
performed shortly after collection, as previously described w48,
53, 55x. The results of these tests were used for clinical man-
agement. Amniotic fluid IL-6 concentrations were used only for
research purposes. Amniotic fluid not required for clinical
assessment was centrifuged for 10 min at 48C, and the super-
natant was aliquoted and stored at –708C until analysis. Among
patients with spontaneous preterm labor with intact membranes
who delivered within 72 hours of amniocentesis, placenta,
umbilical cord, and chorioamniotic membranes were collected
and the presence or absence of histologic chorioamnionitis and
funisitis was assessed. This period of time was selected to pre-
serve a meaningful temporal relationship between amniotic fluid
Ang-2 concentration and placental pathologic findings.
All women provided written informed consent prior to the col-
lection of amniotic fluid. The collection of amniotic fluid and its
utilization for research purposes was approved by the Institu-
tional Review Boards of Wayne State University (Detroit,
Michigan, USA), Sotero del Rio Hospital (Santiago de Chile,
Chile) and the Eunice Kennedy Shriver National Institute of Child
Health and Human Development, NIH, DHHS. Many of these
samples have been previously used to study the biology of
inflammation, hemostasis, and growth factor concentrations in
normal pregnant women and those with pregnancy compli-
cations.
Determination of human Ang-2 concentration in
amniotic fluid
Specific and sensitive enzyme-linked immunoassay (R&D Sys-
tem, Inc. Minneapolis, MN, USA) was used to determine con-
centrations of Ang-2 in human amniotic fluid. The concentrations
of Ang-2 in amniotic fluid samples were determined by inter-
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Table 2 Demographic and clinical characteristics of patients presenting with spontaneous preterm labor with intact membranes.
PTL p PTL pa PTL pb
without IAI without IAI with IAI
term delivery preterm delivery preterm delivery
(ns152) (ns107) (ns82)
Maternal age (years) 23 (19–30) NS 22 (19–30) NS 23 (19–29) NS
Smoking 18.4 (28/151) NS 10.3 (11/105) -0.01 29.3 (24/78) -0.05
BMI (kg/m2) 22.7 (20.1–25.6) NS 22.1 (20.0–25.7) -0.01 25 (21.1–30.1) -0.01
Obesity 8.7 (12/138) NS 11.4 (11/96) -0.05 25.3 (16/63) -0.01
(BMIG30 kg/m2)
GA at amniocentesis 31.8 (29.6–33.3) NS 31.9 (29.7–33.0) -0.01 28.8 (25.2–33.0) -0.001
(weeks)
GA at delivery 38.7 (37.9–39.7) -0.001 34.5 (33.1–35.6) -0.001 30.8 (25.8–33.2) -0.001
(weeks)
Birthweight (grams) 3160 (2880–3530) -0.001 2320 (1940–2670) -0.001 1240 (750–2110) -0.001
Values expressed as percentage (number) or median (inter-quartile range).
p: comparison between PTL who delivered at term and PTL without IAI.
pa: comparison between PTL who delivered preterm without IAI and PTL with IAI.
pb: comparison between PTL who delivered at term and PTL with IAI.
PTL, preterm labor; GA, gestational age; BMI, body mass index; IAI, intra-amniotic infection/inflammation; NS, not significant.
Table 1 Demographic and clinical characteristics of patients in the mid-trimester and those at term with and without spontaneous
labor.
Mid-trimester pa Term no labor Term in labor pb
(ns52) (ns45) (ns48)
Maternal age (years) 36.5 (35–38) -0.001 26 (21–31) 22 (20–28) -0.05
Gestational age at 16 (16.0–17.0) -0.001 38.7 (38.0–39.0) 38.5 (38.0–39.3) NS
amniocentesis (weeks)
Gestational age at 39 (38.0–40.0) NS 38.7 (38.0–39.0) 38.5 (38.0–39.3) NS
delivery (weeks)
Birthweight (grams) 3344 NS 3260 3375 NS
(3128–3596) (3110–3630) (3100–3550)
Values are expressed as median (inter-quartile range).
NS: not significant.
pa: comparison between patients in the mid-trimester and those at term not in labor.
pb: comparison between patients at term not in labor and those at term in labor.
polation from individual standard curves composed of recom-
binant human Ang-2. The calculated inter- and intra-assay
coefficients of variation for Ang-2 immunoassays in our labora-
tory were 3.1% and 3.8%, respectively. The lower limit of detec-
tion of the Ang-2 immunoassay was calculated to be 17.9 pg/mL.
Statistical analysis
The normality of the data was tested using the Shapiro–Wilk and
Kolmogorov–Smirnov tests. Because amniotic fluid Ang-2 con-
centrations were not normally distributed, non-parametric tests
were used for analyses. Comparisons between proportions were
performed with x2-test. Kruskal–Wallis with post-hoc analysis
and Mann–Whitney U-tests were employed for continuous
variables. Adjustment for multiple comparisons was performed
using the Bonferroni method w5x. Spearman rank correlation was
utilized to assess correlations between amniotic fluid concentra-
tions of Ang-2, glucose, IL-6 and WBC count. A P-0.05 was
considered statistically significant. The statistical package used
was SPSS v.15.0 (SPSS Inc., Chicago, IL, USA).
Results
Demographic and clinical characteristics of the
study population
Four hundred and eighty-six patients were included in
the study. Table 1 shows the demographic and clinical
characteristics of the patients in the mid-trimester, term
not in labor and term in labor groups. Table 2 displays
the demographic and clinical characteristics of the
patients with spontaneous preterm labor and intact
membranes. The median body mass index (BMI), and the
rates of smoking and obesity (BMI G30 kg/m2) were sig-
nificantly higher in patients with PTL with IAI and preterm
delivery than in those without IAI and preterm delivery
and those without IAI and term delivery. In addition, the
gestational age at amniocentesis, the gestational age at
delivery and birthweight were significantly lower in
patients with PTL with IAI and preterm delivery than that
506 Pacora et al., Angiopoietin-2 in amniotic fluid
Article in press - uncorrected proof
Figure 1 Amniotic fluid concentration of angiopoietin-2 (Ang-2) in normal pregnancies in the mid-trimester and in those at term
without labor. The median amniotic fluid concentration of Ang-2 was significantly higher in the mid-trimester than in pregnancies at
term not in labor wterm not in labor: 1877.4 pg/mL, inter-quartile range (IQR) 1322.6–2434.1 vs. mid-trimester: 3525.2 pg/mL, IQR
2574.3–4852.2; P-0.001x.
of those without IAI and preterm delivery and those with-
out IAI and term delivery.
Amniotic fluid Ang-2 concentration decreases
with gestational age and does not change in
spontaneous labor at term
Ang-2 was detected in all amniotic fluid samples. Women
with a normal pregnancy at term not in labor had a sig-
nificantly lower median Ang-2 concentration in amniotic
fluid than those in the mid-trimester wterm not in labor:
1877.4 pg/mL, inter-quartile range (IQR) 1322.6–2434.1
vs. mid-trimester: 3525.2 pg/mL, IQR 2574.3–4852.2;
P-0.001x (Figure 1). In contrast, no significant differences
were observed in the median amniotic fluid Ang-2 con-
centration between patients with spontaneous labor at
term and those at term not in labor (term in labor:
1722.6 pg/mL, IQR 1293.5–2499.3 vs. term not in labor:
1877.4 pg/mL, IQR 1322.6–2434.1; Ps0.6).
Ang-2 concentration is increased in the amniotic
fluid of women with spontaneous preterm labor
with intact membranes with intra-amniotic
infection/inflammation
Patients with spontaneous preterm labor with IAI had a
significantly higher median amniotic fluid concentration
of Ang-2 than those who delivered preterm without
IAI (PTL with IAI: 4041.3 pg/mL, IQR 2463.0–6385.3 vs.
PTL without IAI: 2599.4 pg/mL, IQR 1822.3–4145.8;
P-0.001) and than patients with spontaneous preterm
labor who delivered at term (PTL delivered at term:
2707.3 pg/mL, IQR 1791.9–4274.4; P-0.001) (Figure 2).
After adjusting for gestational age at amniocentesis and
storage time, similar results were obtained (ANCOVA,
Ps0.02 among subgroups comparisons). There were no
differences in the median amniotic fluid Ang-2 concen-
tration between patients with spontaneous preterm labor
without IAI who delivered preterm and those who deliver-
ed at term (PTL without IAI: 2599.4 pg/mL, IQR 1822.3–
4145.8 vs. PTL delivered at term: 2707.3 pg/mL, IQR
1791.9–4274.4; Ps0.6) (Figure 2).
When the analysis was restricted to patients with
spontaneous preterm labor without IAI who delivered
within 72 h from the amniocentesis (ns18), this sub-
group had a similar median amniotic fluid concentration
of Ang-2 compared to those with spontaneous preterm
labor with intact membranes who delivered at term (PTL
without IAI with delivery within 72 h: 2460.5 pg/mL, IQR
1648.7–4162.8 vs. PTL delivered at term: 2707.3 pg/mL,
IQR 1791.9–4274.4; Ps0.4).
Amniotic fluid Ang-2 concentrations in patients
with histologic chorioamnionitis and funisitis
Placental histopathologic diagnoses were available in
77% (54/70) of patients with spontaneous preterm labor
who delivered within 72 h of amniocentesis. Of those,
Pacora et al., Angiopoietin-2 in amniotic fluid 507
Article in press - uncorrected proof
Figure 2 Amniotic fluid concentration of angiopoietin-2 (Ang-2) among women with intra-amniotic infection/inflammation in spon-
taneous preterm labor with intact membranes. The median amniotic fluid concentration of Ang-2 in patients with spontaneous preterm
labor with IAI was significantly higher than that of those who delivered preterm without IAI (PTL with IAI: 4041.3 pg/mL, IQR
2463.0–6385.3 vs. PTL without IAI: 2599.4 pg/mL, IQR 1822.3–4145.8; P-0.001) and that of patients with spontaneous preterm
labor who delivered at term (PTL delivered at term: 2707.3 pg/mL, IQR 1791.9–4274.4; P-0.001). There were no differences in the
median amniotic fluid Ang-2 concentration between patients with spontaneous preterm labor without IAI who delivered preterm and
those who delivered at term (PTL without IAI: 2599.4 pg/mL, IQR 1822.3–4145.8 vs. PTL delivered at term: 2707.3 pg/mL, IQR
1791.9–4274.4; Ps0.6).
52% (28/54) had evidence of placental inflammation.
Patients with histologic chorioamnionitis and/or funisitis
(ns28) had higher median Ang-2 concentration in amnio-
tic fluid than those (ns26) without histologic chorioam-
nionitis, but this difference was not statistically significant
(histologic chorioamnionitis: median 4693.3 pg/mL,
IQR 2242.3–8054.5 vs. non-histological choriamnionitis:
median 3180.9 pg/mL, IQR 1690.1–5310.1, Ps0.09).
Amniotic fluid Ang-2 concentration correlated
with IL-6 in spontaneous preterm labor
In patients with spontaneous preterm labor, a weak but
significant correlation was observed between amniotic
fluid concentration of Ang-2 and those of IL-6 (Spear-
man’s rho coefficient: IL-6: 0.27, P-0.001), but not with
amniotic fluid glucose concentration or WBC count
(glucose: –0.09, Ps0.09 and WBC count: 0.08, Ps0.1).
Discussion
Principal findings of the study
1) Ang-2 is a physiologic constituent of the amniotic fluid;
2) Ang-2 concentration in amniotic fluid is significantly
higher in the presence of IAI in patients with preterm
labor with intact membranes; 3) amniotic fluid Ang-2 con-
centrations correlated with those of IL-6 in patients with
IAI; and 4) the amniotic fluid Ang-2 concentration
decreased with advancing gestation, and did not change
in spontaneous labor at term.
What is Ang-2?
Ang-2 is a 66 kDa polypeptide that contains 496 amino
acids, is 60% homologous to Ang-1, and promotes
angiogenesis w33x. Although, both Ang-1 and Ang-2 are
encoded by genes localized on chromosome 8 w9x and
share a similar protein structure, their biological activities
are different. Ang-2 is classically considered as a Tie-2
antagonist, and it is accepted that at sites of vascular
remodeling, Ang-2 counteracts the stabilizing action of
Ang-1 by exposing the endothelium to pro-angiogenic
factors such as VEGF. This antagonistic role of Ang-2
was first suggested when its overexpression resulted in
the impairment of blood vessel formation in transgenic
mice, a phenotype similar to the one obtained in Ang-1
and Tie-2 knockout mice w33x. However, studies with
Ang-2 knockout mice suggest that this role would not be
restricted to counteracting Ang-1 activities. Ang-2 may
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also act as a Tie-2 agonist, being involved in postnatal
vascular remodeling events w18x, because Ang-2 can
activate Tie-2 and stimulate both endothelial cell migra-
tion and endothelial cell capillary-like tube formation in
vitro w38, 64x. In addition to their roles in angiogenesis,
angiogenic factors increase vascular permeability w3, 42x
and can be expressed during the course of inflammation.
Ang-2 concentration in amniotic fluid decreases
with advancing gestational age in normal human
pregnancy
Human pregnancy is characterized by angiogenesis, tis-
sue development and remodeling w19, 67, 70x. In the ear-
ly phase of development, vascular endothelial growth
factor-A (VEGF-A) and placental growth factor (PlGF) play
an important role in angiogenesis w13, 15x. Human tro-
phoblast expresses PlGF, but VEGF-A is expressed in
villous and decidual macrophages w11x. Vascular endo-
thelial growth factor interacts with vascular endothelial
growth factor receptor 1 (VEGFR-1; Flt-1) and vascular
endothelial growth factor receptor 2 (VEGFR-2; KDR) to
promote endothelial cell proliferation, cell migration, and
vascular permeability w67, 70x. In a later phase, Ang-1,
Ang-2 participate in angiogenesis w44, 70x.
Ang-1 and Ang-2 bind with equal affinity to Tie-2, but
have different functions. Ang-1 maintains vessel integrity
and plays a role in the later stages of vascular remodeling
w20x. Ang-2 is a functional antagonist of Ang-1, and leads
to loosening of cell/cell interactions and allows access to
angiogenic inducers such as VEGF w33x. When VEGF is
present, Ang-2 promotes vascular growth, but when
VEGF is absent, vascular regression occurs w2, 33x. Ang-2
is selectively expressed at sites of active angiogenesis,
such as the ovary, uterus, and placenta w2, 33x.
Our finding of higher amniotic fluid concentration of
Ang-2 in mid-trimester than that of term gestation are
consistent with those of Zhang et al. w70x who, perform-
ing in situ hybridization studies, have shown that Ang-2
mRNA was readily detected in the syncytiotrophoblast in
the first trimester human placenta, but at term, only low
levels of Ang-2 mRNA were detected w70x. Both findings
suggest that the amniotic cavity is one of the most active
sites of angiogenesis during the first half of pregnancy.
We propose two explanations for the decrease of amnio-
tic fluid Ang-2 concentration with gestational age. First,
normal term pregnancy is characterized by a lower
angiogenesis activity than that of early pregnancy. For
instance, the median amniotic fluid concentration of sol-
uble fms-like tyrosine kinase-1 (sFlt-1 or soluble recep-
tor-1 of VEGF: sVEGFR-1), an inhibitor of the activity of
VEGF and PlGF, at mid-trimester is one-third of that at
normal term pregnancy (10,236 pg/mL vs. 33,490 pg/mL)
w43, 62x. As normal pregnancy approach to term, a
switch off of the angiogenesis process might occur.
Second, there might be a dynamic transfer of Ang-2 into
the fetal vessels through an increase in intramembranous
absorption in the amniotic cavity that occurs at term ges-
tation w7, 14x. We have detected Ang-2 mRNA expression
in human amnion, which might be a source of amniotic
fluid Ang-2 (unpublished data). Since there is a vascular
pathway in the fetal surface of the placenta and within
the fetal membranes which serves as the primary site for
transfer of water and solutes from the amniotic com-
partment across the amnion into fetal blood within the
placenta and fetal membranes w6, 10, 57x, the decreased
amniotic fluid Ang-2 concentration at term might be an
effect of the dilution of the protein in the amniotic cavity
because there is an increased placental water flux with
advancing gestation from the mother to the fetus w4x.
Aquaporin-1, a cell membrane water channel that regu-
lates the flow of water across a variety of cell mem-
branes, has been detected in the epithelium of the
chorionic plate amnion, suggesting that aquaporin-1
rapidly facilitates water transport between the amniotic
cavity and the fetal circulation w35x.
Ang-2 in amniotic fluid is increased in
intra-amniotic infection and inflammation
A novel observation of this study is that the median amni-
otic fluid Ang-2 concentration was increased in patients
with IAI who delivered preterm. This finding supports the
view that Ang-2 plays a role in inflammation, and sug-
gests that Ang-2 participates in the host response to
intrauterine infection. In addition, a significant correlation
was observed between the amniotic fluid concentrations
of Ang-2 and that of IL-6. IL-6 is considered a sensitive
and specific marker of intra-amniotic infection w56x and/
or inflammation w68x.
Unlike Ang-1, which protects adult peripheral vascu-
lature from vascular leakage and inhibits the effects of
proinflammatory cytokines on endothelial cells w29, 30,
66x, the effect of Ang-2 on angiogenesis is more complex
and is context dependent; when Ang-2 concentrations
are elevated, angiogenesis is enhanced when VEGF is
present, whereas vascular regression has been observed
in its absence w27x.
The concept that Ang-2 may promote inflammation is
based on the following findings: 1) pro-inflammatory
cytokines strongly activate Ang-2 transcription in endo-
thelial cells w26, 28, 33, 34x; 2) elevated serum concen-
trations of Ang-2 are present in patients with sepsis w21,
39, 42x; 3) the injection of Ang-2 protein in vivo elicits a
significant increase in edema formation in the mouse paw
w58x; and 4) Ang-2 deficient mice have an impaired ability
to express cytokine-inducible adhesion molecules on
endothelial cell surfaces after inflammatory activation
w16x.
Since intrauterine inflammation/infection is character-
ized by elevated pro-inflammatory cytokine concentra-
tion in amniotic fluid w49, 50, 56, 68x, the findings of our
study support a role of amniotic fluid Ang-2 in the patho-
logic inflammation elicited by microbial agents or its
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products in the process of preterm parturition. Ang-2
acts by an autocrine mechanism w17x and is stored in
endothelial Weibel-Palade bodies from where it can be
rapidly released upon stimulation w16x. Inflammation
exists in a mutually dependent association with angio-
genesis w37, 61x. Indeed, during an inflammatory pro-
cess, newly formed vessels supply the inflamed tissues
with nutrients and oxygen allowing the transport of
inflammatory cells. Among these, neutrophils are the first
cells recruited in the angiogenic bed and provide cyto-
kines, growth factors, and proteolytic enzymes, which
contribute to regulate angiogenesis w32, 45, 59x. It has
been shown also that neutrophil granules contain a vari-
ety of preformed pro-angiogenic proteins and may pro-
mote the development of laser induced choroidal
neovascularization in the retina at the early stage by pro-
viding preformed pro-angiogenic factors including VEGF,
Ang-1, Ang-2, and MMP-9 w71x.
Since we did not find a significant correlation between
amniotic fluid Ang-2 concentration and the number of
amniotic fluid WBC, Ang-2 found in the amniotic fluid is
most likely to originate from other tissues, such as
amnion. We could detect angiopoiein-2 mRNA expres-
sion in human amnion, and its expression was increased
in the presence of chorioamnionitis (unpublished data).
Our preliminary observations strongly suggest that Ang-2
could be released into the amniotic cavity from the
amnion.
Ang-2 in amniotic fluid and parturition
Human parturition has a common pathway characterized
by increased uterine contractility, cervical ripening/dila-
tation, and membrane/decidual activation, culminating in
membrane rupture w46, 47, 51x. This activation is gen-
erally a coordinated inflammatory phenomenon in normal
spontaneous labor at term w40, 65, 69x. In addition, labor
at term induces gene expression changes in chorioam-
niotic membranes consistent with a localized acute
inflammatory response, despite the absence of histologic
evidence of inflammation w23x. Moreover, spontaneous
labor at term, as well as pathologically induced preterm
labor, result in greatly increased expression of angioge-
nesis-related genes in the mouse uterus w23x.
Our finding that Ang-2 did not change in the presence
of human term labor is unexpected and may have three
possible explanations. First, physiological human partu-
rition at term may not be associated with changes in the
amniotic fluid Ang-2 concentrations because, as normal
pregnancy approaches to term, a switch off of the angio-
genesis process might occur w43, 62x. This explanation
agrees with our finding that amniotic fluid Ang-2 increas-
es only when there is IAI. Indeed, the mean concentration
of amniotic fluid Ang-2 of patients without IAI who deliv-
ered preterm was not different than that of patients with
preterm labor without IAI who delivered at term (Figure
2). A physiologic inflammatory process might be different
than that of pathologic inflammation. Second, the
increased concentration of the angiopoietin receptor
Tie-2 in term spontaneous labor might have dampened
the amniotic fluid Ang-2 concentration during labor,
because the expression of Tie-2 in amnion and chorio-
decidua of patients with spontaneous term labor is great-
er than that of those at term not in labor w35x. Third,
human amnion is a biologically heterogenous and com-
partmentalized tissue w25x and, therefore, amniotic fluid
Ang-2 production in the upper compartment may not
change before the onset of labor. Further research is war-
ranted to test these hypotheses.
Conclusions
We report an association between Ang-2 concentrations
in amniotic fluid and intra-amniotic infection and/or
inflammation. These results suggest that Ang-2 plays a
role in normal gestation, as well as in preterm labor with
IAI.
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